The Antiviral Activity of GcMAF in the Treatment of Experimental Animals Infected with SARS-CoV-2

The Antiviral Activity of GcMAF in the Treatment of Experimental Animals Infected with SARS-CoV-2

Despite the end of the COVID-19 pandemic, there still remain risks of new aggressive strains of coronavirus. As the human population increases progressively, it is mandatory to ensure both preventive measures and an immediate response to emerging infectious threats. Another essential component for r...

Full description

Saved in:
Bibliographic Details
Main Authors: Anastasia S. Proskurina, Oleg S. Taranov, Svetlana S. Kirikovich, Svetlana V. Aidagulova, Elena K. Ivleva, Andrey V. Shipovalov, Gleb A. Kudrov, Sergei A. Bodnev, Alena S. Ovchinnikova, Anna V. Zaykovskaya, Oleg V. Pyankov, Evgeniy V. Levites, Genrikh S. Ritter, Vera S. Ruzanova, Sofya G. Oshikhmina, Evgeniya V. Dolgova, Evgeniy L. Zavjalov, Alexandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Sergey S. Bogachev
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:COVID
Subjects:
COVID-19
cytokine
peritoneal macrophage
Syrian hamster
vitamin D-binding protein
Online Access:https://www.mdpi.com/2673-8112/5/3/36
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items